In addition, advances in delivery strategies, including nanocarrier-based and stimuli-responsive systems, are reviewed for their roles in improving the bioavailability, stability, and tumor targeting of natural metabolism-regulating agents
Each batch is independently tested by Eurofins, a global leader in laboratory testing, to help ensure it meets our standards for safety and consistency
Morimoto, S
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health grants DK021397 (to M.R.H.) and DK112812 (to B.C.D.J.) and Swiss National Science Foundation (SNSF) grant P400PB_186728 (to T.B.)
Recalls & Warnings December 26, 2017 Seller of BrainAlert Warned for Manufacturing Violations, Drug Claims On December 14, 2017, the FDA issued a warning letter to BrainAlert, LLC
10.1038/sj.jid.5700700 J